Search Results - "Hoeks, Marlijn"

Heparin-resistance in AL amyloidosis: a case report by van Ede, Elisabeth S, Hoeks, Marlijn P A, Hofland, Jan, Linssen, Vera D, van Kuppevelt, Toin H, Versteeg, Elly M, Hafmans, Theo G, Diepstra, Arjan, Kusters, Benno, Vermorgen, Sanne M M

“…Non-AT-III mediated heparin-resistance during CPB occurs by complex-forming with heparin-binding proteins. Currently, there are no specific recommendations for…”
Get full text

Safety and efficacy of a Hb‐triggered single‐unit red cell transfusion policy for haemato‐oncological inpatients by Bosch, Milou, Lil, Heleen S., Oomen, Jesse J, Eijsink, Chantal, Blijlevens, Nicole M. A., Hoeks, Marlijn P. A., Evers, Dorothea

Get full text

Impact of red blood cell transfusion strategies in haemato‐oncological patients: a systematic review and meta‐analysis by Hoeks, Marlijn P. A., Kranenburg, Floris J., Middelburg, Rutger A., Kraaij, Marian G. J., Zwaginga, Jaap‐Jan

“…Summary Haemato‐oncological patients receive many red blood cell (RBC) transfusions, however evidence‐based guidelines are lacking. Our aim is to quantify the…”
Get full text

Gastrointestinal Angiodysplasia Resolution After Transcatheter Aortic Valve Implantation by Goltstein, Lia C M J, Rooijakkers, Maxim J P, Thierens, Naomi D E, Schoormans, Selene C M, van Herwaarden, Antonius E, Beaumont, Hanneke, Houdeville, Charles, Hoeks, Marlijn P A, van Geenen, Erwin-Jan M, Rijpma, Sanna R, Dray, Xavier, van Royen, Niels, Drenth, Joost P H

“…Heyde syndrome is the cooccurrence of aortic stenosis and gastrointestinal bleeding secondary to vascular lesions, including angiodysplasias. Several studies…”
Get full text

Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease by Jalink, Marit, Jacobs, Chaja F., Khwaja, Jahanzaib, Evers, Dorothea, Bruggeman, Coty, Fattizzo, Bruno, Michel, Marc, Crickx, Etienne, Hill, Quentin A., Jaeger, Ulrich, Kater, Arnon P., Mäkelburg, Anja B. U., Breedijk, Anouk, te Boekhorst, Peter A. W., Hoeks, Marlijn P. A., de Haas, Masja, D’Sa, Shirley, Vos, Josephine M. I.

“…•Daratumumab monotherapy may be an effective and well-tolerated treatment in more than half of patients with refractory AIHA and cold agglutinin…”
Get full text

The development of polycythemia vera after phlebotomy treatment for hereditary haemochromatosis by Bommel, Erik JM, Kelder, Denise, Hoeks, Marlijn PA, Herbers, Alexandra HE

“…INTRODUCTION Hereditary haemochromatosis (HH) is an autosomal recessive disorder, related to mutations in the HFE gene, characterized by increased intestinal…”
Get full text

Improving a Rare Metabolic Disorder Through Kidney Transplantation: A Case Report of a Patient With Lysinuric Protein Intolerance by IJzermans, Ties, van der Meijden, Wilbert, Hoeks, Marlijn, Huigen, Marleen, Rennings, Alexander, Nijenhuis, Tom

“…Lysinuric protein intolerance (LPI) is a rare metabolic disorder with reduced renal and intestinal reabsorption of ornithine, lysine, and arginine. It is due…”
Get full text

Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis by Goltstein, Lia C M J, Rooijakkers, Maxim J P, Hoeks, Marlijn, Li, Wilson W L, van Wely, Marleen H, Rodwell, Laura, van Royen, Niels, Drenth, Joost P H, van Geenen, Erwin-Jan M

“…Abstract Aims Heyde syndrome is the co-occurrence of aortic stenosis, acquired von Willebrand syndrome, and gastrointestinal bleeding. Aortic valve replacement…”
Get full text

Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n‐of‐1 trial of weekly‐interval red cell transfusion in myelodysplastic syndromes by Mo, Allison, Wood, Erica, Shortt, Jake, Charlton, Andrew, Evers, Dorothea, Hoeks, Marlijn, Pritchard, Elizabeth, Daly, James, Hodgson, Carol, Opat, Stephen, Bowen, David, Reynolds, John, Thi Phung Thao, Le, Stanworth, Simon J., McQuilten, Zoe

“…Background Anemia in myelodysplastic syndromes (MDS) is associated with poorer health‐related quality of life (HRQoL) and physical function, and is frequently…”
Get full text

Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes by de Swart, Louise, Crouch, Simon, Hoeks, Marlijn, Smith, Alex, Langemeijer, Saskia, Fenaux, Pierre, Symeonidis, Argiris, Cermâk, Jaroslav, Hellström-Lindberg, Eva, Stauder, Reinhard, Sanz, Guillermo, Mittelman, Moshe, Holm, Mette Skov, Malcovati, Luca, Mądry, Krzysztof, Germing, Ulrich, Tatic, Aurelia, Savic, Aleksandar, Almeida, Antonio Medina, Gredelj-Simec, Njetocka, Guerci-Bresler, Agnes, Beyne-Rauzy, Odile, Culligan, Dominic, Kotsianidis, Ioannis, Itzykson, Raphael, van Marrewijk, Corine, Blijlevens, Nicole, Bowen, David, de Witte, Theo

“…Progression-free survival (PFS) of patients with lower-risk myelodysplastic syndromes (MDS) treated with red blood cell transfusions is usually reduced, but it…”
Get full text

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry by Hoeks, Marlijn, Yu, Ge, Langemeijer, Saskia, Crouch, Simon, de Swart, Louise, Fenaux, Pierre, Symeonidis, Argiris, Čermák, Jaroslav, Hellström-Lindberg, Eva, Sanz, Guillermo, Stauder, Reinhard, Holm, Mette Skov, Mittelman, Moshe, Mądry, Krzysztof, Malcovati, Luca, Tatic, Aurelia, Almeida, Antonio Medina, Germing, Ulrich, Savic, Aleksandar, Šimec, Njetočka Gredelj, Culligan, Dominic, Itzykson, Raphael, Guerci-Bresler, Agnes, Slama, Borhane, Droste, Jackie, van Marrewijk, Corine, van de Loosdrecht, Arjan, Blijlevens, Nicole, van Kraaij, Marian, Bowen, David, de Witte, Theo, Smith, Alex

“…Iron overload due to red blood cell (RBC) transfusions is associated with morbidity and mortality in lower-risk myelodysplastic syndrome (MDS) patients. Many…”
Get full text

Bone marrow iron score as an indicator for secondary iron overload in acute myeloid leukemia patients by Hoeks, Marlijn, van der Pol, Marit, Middelburg, Rutger, Evers, Dorothea, van Kraaij, Marian, Zwaginga, Jaap Jan

“…Objectives Secondary iron overload due to red blood cell transfusions (RBCT) is associated with increased morbidity and mortality. However, attention for…”
Get full text

Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome by Hoeks, Marlijn, Bagguley, Tim, van Marrewijk, Corine, Smith, Alex, Bowen, David, Culligan, Dominic, Kolade, Seye, Symeonidis, Argiris, Garelius, Hege, Spanoudakis, Michail, Langemeijer, Saskia, Roelofs, Rian, Wiegerinck, Erwin, Tatic, Aurelia, Killick, Sally, Panagiotidis, Panagiotis, Stanca, Oana, Hellström-Lindberg, Eva, Cermak, Jaroslav, van der Klauw, Melanie, Wouters, Hanneke, van Kraaij, Marian, Blijlevens, Nicole, Swinkels, Dorine W., de Witte, Theo

Get full text

Specific proteome changes in platelets from individuals with GATA1-, GFI1B-, and RUNX1-linked bleeding disorders by Van Bergen, M.G.J.M., Marneth, A.E., Hoogendijk, A.J., Van Alphen, F.P.J., Van den Akker, E., Laros-Van Gorkom, B.A.P., Hoeks, M., Simons, A., De Munnik, S.A., Janssen, J.J.W.M., Martens, J.H.A., Jansen, J.H., Meijer, A.B., Van der Reijden, B.A.

“…Mutations in the transcription factors GATA binding factor 1 (GATA1), growth factor independence 1B (GFI1B), and Runt-related transcription factor 1 (RUNX1)…”
Get full text

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective by De Witte, Theo, Malcovati, Luca, Fenaux, Pierre, Bowen, David, Symeonidis, Argiris, Mittelman, Moshe, Stauder, Reinhard, Sanz, Guillermo, Čermák, Jaroslav, Langemeijer, Saskia, Hellström-Lindberg, Eva, Germing, Ulrich, Skov Holm, Mette, Mądry, Krzysztof, Tatic, Aurelia, Medina Almeida, António, Savic, Aleksandar, Mandac Rogulj, Inga, Itzykson, Raphael, Hoeks, Marlijn, Gravdahl Garelius, Hege, Culligan, Dominic, Kotsianidis, Ioannis, Ades, Lionel, Van de Loosdrecht, Arjan A, Van Marrewijk, Corine, Yu, Ge, Crouch, Simon, Smith, Alex

Get full text

ENDOSCOPIC RESOLUTION OF ANGIODYSPLASIAS FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION IN HEYDE SYNDROME: A PROSPECTIVE COHORT STUDY by Goltstein, Lia, Rooijakkers, Maxim, Thierens, Naomi, Schoormans, Selene, Beaumont, Hanneke, Houdeville, Charles, Hoeks, Marlijn, Geenen, Erwin-Jan van, Rijpma, Sanna, Dray, Xavier, van Royen, Niels, Drenth, Joost

Get full text

Impact of Red Blood Cell Transfusion Intensity on Progression-Free Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS Registry by De Swart, Louise, Crouch, Simon, Hoeks, Marlijn, Smith, Alex, Langemeijer, Saskia, Fenaux, Pierre, Symeonidis, Argiris, Cermak, Jaroslav, Stauder, Reinhard, Mittelman, Moshe, Sanz, Guillermo, Hellstrom-Lindberg, Eva, Malcovati, Luca, Holm, Mette Skov, Germing, Ulrich, Madry, Krzysztof, Almeida, Antonio Medina de, Tatic, Aurelia, Savic, Aleksandar, Gredelj-Šimec, Njetočka, Guerci Bresler, Agnes, Culligan, Dominic, Itzykson, Raphael, Beyne-Rauzy, Odile, Park, Sophie, van Marrewijk, Corine, Blijlevens, Nicole M A, Bowen, David T., de Witte, T.M.

“…▪ Background Progression-free survival (PFS) of lower-risk (LR) MDS patients treated with red blood cell transfusions (RBCT) is usually reduced, but whether…”
Get full text

Impact of Treatment with Iron Chelation Therapy in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry by Hoeks, Marlijn, Yu, Ge, Langemeijer, Saskia, Crouch, Simon, De Swart, Louise, Fenaux, Pierre, Symeonidis, Argiris, Cermak, Jaroslav, Hellstrom-Lindberg, Eva, Sanz, Guillermo, Stauder, Reinhard, skov-Holm, Mette, Mittelman, Moshe, Madry, Krzysztof, Malcovati, Luca, Tatic, Aurelia, Almeida, Antonio Medina de, Germing, Ulrich, Savic, Aleksandar, Gredelj-Šimec, Njetočka, Culligan, Dominic, Itzykson, Raphael, Guerci-Bresler, Agnes, Slama, Borhane, van Marrewijk, Corine, Droste, Jackie, van Kraaij, Marian, Bowen, David T., de Witte, T. M. M, Smith, Alex

“…BackgroundIron overload/toxicity due to red blood cell transfusions (RBCT) is associated with morbidity and mortality in various patient groups, including…”
Get full text

Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival by Hoeks, Marlijn, Bagguley, Tim, Roelofs, Rian, De Swart, Louise, Bowen, David, Symeonidis, Argiris, van Marrewijk, Corine, Hellström-Lindberg, Eva, Tatic, Aurelia, Langemeijer, Saskia, Culligan, Dominic J., Macheta, Marian, Garelius, Hege, Spanoudakis, Michail, Killick, Sally, Panagiotidis, Panagiotis, Stanca Ciocan, Oana, Mills, Juliet, Pottinger, Bryson, Ackroyd, Sam, Hall, Claire, Droste, Jackie, Smith, Alexandra, Swinkels, Dorine W., de Witte, Theo M

“…Background: Patients with lower-risk MDS (LR-MDS) are prone to iron toxicity due to long-term iron accumulation either caused by RBC transfusions or…”
Get full text

Elevated Labile Plasma Iron Levels (LPI) and Increased Oxidative Stress Are Associated with Red Blood Cell Transfusions in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Subtitle: from the European Leukemianet MDS Registry by Hoeks, Marlijn, Langemeijer, Saskia, De Swart, Louise, Bagguley, Tim, van Marrewijk, Corine, Bowen, David, Cermak, Jaroslav, Hellstrom-Lindberg, Eva, Tatic, Aurelia, Symeonidis, Argiris, Van Kraaij, Marian G.J., Panagiotidis, Panagiotis, Garelius, Hege, Culligan, Dominic J, Krejci, Marta, Droste, Jackie, Smith, Alexandra, Swinkels, Dorine W., de Witte, Theo

“…Background: The EUMDS registry, collecting prospective observational data on lower-risk MDS (LR-MDS) patients from 142 centers in 17 countries, is performing a…”
Get full text